ERS School Course on Monitoring of airway diseases, Lausanne 2004

ERS School Course on Monitoring of airway diseases, Lausanne 2004

Introduction, overview on different ways of monitoring airway diseases

B. Balbi (Gussago, Italy)

How to value clinical presentation (symptom score, quality of life questionnaires)

G. Joos (Gent, Belgium)

Lung function measurements, PEF monitoring

E. Bel (Leiden, The Netherlands)

Asthma specific test vs COPD specific test

B. Balbi (Gussago, Italy)

Measurements of airway hyperresponsiveness - Direct challenges

E. Bel (Leiden, The Netherlands)

Measurements of airway hyperresponsiveness - Indirect challenges

G. Joos (Gent, Belgium)

Methodological considerations of sputum induction

R. Louis (Liege, Belgium)

Applications of induced sputum sampling in asthma

R. Green (Leicester, United Kingdom)

Applications of induced sputum sampling in COPD

R. Louis (Liege, Belgium)

Use of induced sputum in other airway diseases

R. Green (Leicester, United Kingdom)

Special considerations in sputum induction in children

N. Wilson (London, United Kingdom)

Comparison of induced sputum results with other markers of airway diseases

A. Spanevello (Tradate, Italy)

How to measure exhaled and nasal nitric oxide and other exhaled volatiles and their clinical application

P. Paredi (London, United Kingdom)

Applications of exhaled and nasal NO in airway diseases

S. A. Kharitonov (London, United Kingdom)

Methodology of exhaled breath condensate collection and mediator determination

I. Horváth (Budapest, Hungary)

Markers of airway diseases in exhaled breath condensate

M. Corradi (Parma, Italy)

Special issues of exhaled breath biomarkers measurements in children

N. Wilson (London, United Kingdom)

Comparison of exhaled biomarkers to other local and systemic markers of airway diseases

S. A. Kharitonov (London, United Kingdom)